100%(10)10 out of 10 people found this document helpful
This preview shows page 1 - 3 out of 9 pages.
NURS6521wk8d1r1Hi Adriane, Thank you for the informative post you shared. The advancements of antiretroviral therapy (ART) to manage the progression of HIV can improve the health of people affected by the disease and reduce transmission of the virus. Patient adherence is a significant factor to achieve the clinical and health benefits of the therapy. HIV-infected individual's perceived and experienced adverse drug reactions to ART are relevant factors that can influence patient adherence. As studied in an article, when people receiving ART experience benefits of maintaining their health efficiently, had knowledge of adverse drug reactions and practiced coping strategies to manage these side effects, they were more likely to adhere (World Health Organization, 2017). Providing drug information about the role of antiretroviral therapy in controlling the progression of HIV and reducing the risk of transmission will encourage the individual to participate in starting the treatment. However, the role of the clinician does not end on selecting the appropriate drug regimen for ART. Promoting adherence to the treatment plan bycomplying to take the medications as prescribed, regular follow-up and monitoring, managing adverse drug reactions and behavior modifications are essential factors in achieving the desired outcomes of the therapy. As unanticipated occurrences can affect patient’s adherence, information to promote knowledge and understanding of adverse reactions from antiretroviral drugs including support on how to adopt strategies to deal with these effects should be incorporated during the selection of the treatment plan. I agree with you that complacency affecting HIV prevalence is multifactorial and can be related to the development of drugs. The downfall is not directly caused by antiviral drug advancements but can be associated with the deficient implementation of the regimen. As antiretroviral agents provide promising benefits in
controlling the prevalence of HIV and reducing comorbidities and mortalities, the selection of drug and patient education should not only focus on the desired benefits of the medications. Patients starting on ART should be fully informed that besides positive effects, there are risks of adverse reaction and patient adherence is necessary to achieve the suppressed viral load. Additionally, individuals on the therapy should be aware that being on the treatment plan requires a long-term commitment to continually comply with taking medications as prescribed, ongoing follow-up and monitoring including adapting ways to handle unwanted side effects. Reference:World Health Organization. (2017, February). The role of ARV associated adverse drug reactionsin influencing adherence among HIV-infected individuals: a systematic review and qualitative meta-synthesis. Retrieved from